Evaluation of New Monoclonal Antibodies in Detection of Estrogen Receptor, Progesterone Receptor, and Her2 Protein Expression in Breast Carcinoma Cell Block Sections Using Conventional Microscopy and Quantitative Image Analysis

Diagnostic Cytopathology

Volumn 37, Issue 4, 2009, Pages 251-257

  Hanley, K Z ^a   Siddiqui, M T ^a   Lawson, D ^a   Cohen, C ^a   Nassar, A ^b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

ER; Her2 expression; Image analyzer; PR; Rabbit monoclonal antibodies

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; STANDARD;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 65349114842     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20989     Document Type: Article

References (17)

1. Cheang MC, Treaba DO, Speers CH, et al. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol 2006;24:5637-5644.
2. Huang Z, Zhu W, Meng Y, Xia H. Development of new rabbit monoclonal antibody to progesterone receptor (Clone SP2): No heat pretreatment but effective for paraffin section immunohistochemistry. Appl Immunohistochem Mol Morphol 2006;14:229-233.
3. Reid V, Doherty J, McIntosh G, Cowell S, Lee M, Rees M. The first quantitative comparison of immunohistochemical rabbit and mouse monoclonal antibody affinities using biacore analysis. J Histotechnol 2007;30:177-182.
4. Powell WC, Hicks DG, Prescott N, et al. A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: Comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility. Appl Immunohistochem Mol Morphol 2007;15:94-102.
5. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-145.
6. Tawfik OW, Kimler BF, Davis M, et al. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma. Histopathology 2006;48: 258-267.
7. Yaziji H, Gown AM. Accuracy and precision in HER2/neu testing in breast cancer: Are we there yet? Hum Pathol 2004;35:143-146.
8. Huang Z, Zhu W, Szekeres G, Xia H. Development of new rabbit monoclonal antibody to estrogen receptor: Immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol 2005;13:91-95.
9. Rossi S, Laurino L, Furlanetto A, et al. Rabbit monoclonal antibodies: A comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol 2005;124:295-302.
10. Turbin DA, Leung S, Cheang MC, et al. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: A tissue microarray study of 3,484 cases. Breast Cancer Res Treat 2008;110:417-426.
11. Ciampa A, Xu B, Ayata G, et al. HER-2 status in breast cancer: Correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. Appl Immunohistochem Mol Morphol 2006;14:132-137.
12. Anderson JM, Ariga R, Govil H, et al. Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. Appl Immunohistochem Mol Morphol 2003;11:120-124.
13. Bloom K, Harrington D. Enhanced accuracy and reliability of HER- 2/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol 2004;121:620-630.
14. Hoang MP, Sahin AA, Ordonez NG, Sneige N. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 2000;113:852-859.
15. Lebeau A, Deimling D, Kaltz C, et al. Her-2/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol 2001;19:354-363.
16. Yaziji H, Goldstein LC, Barry TS, et al. HER-2 testing in breast cancer using parallel tissue-based methods. JAMA 2004;291:1972-1977.
17. Norton CM, Cohen C, Lawson D, Nassar A. Image cytometric validation of breast carcinoma markers using tissue microarrays: Rabbit monoclonal versus FDA-approved antibodies. Mod Pathol 2008;21 (Suppl 1):368A.